Dr. Galici has a background in Drug Discovery and Clinical Development with expertise in Pharmacology. He has over 15 years of experience successfully and strategically planning and delivering scientific, medical communications and global regulatory submissions to support Oncology, Vaccine, Rare Disease, Neuroscience, Pain, Immunology and Inflammation, and Consumer Health (nutrition, Rx-to-OTC switch) programs. He is currently the co-chair of the DIA MASC forum.

Elizabeth Brown is an Executive Director in Medical Writing & Disclosure at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years, as a laboratory scientist, a clinical researcher, a medical writer and an organizational leader. With her project and people management focus, she has developed a passion for developing people, advising teams, and providing strategic guidance how to create efficient, effective, and high-quality scientific communication deliverables.

Kim Jochman is a Senior Director, Medical Writing at Merck. She has a Ph.D in biological psychology and has been a regulatory medical writer since 2007, with experience across a broad range of document types, development phases, and therapeutic areas. Kim is passionate about training, mentoring, and process optimization. In her current role, she leads a variety of training, technical, and strategic initiatives to maximize the quality and efficiency of the authoring process. These include developing & leading training programs for early career Medical Writers, conducting industry trainings on lean authoring & data interpretation, and supporting technology initiatives at Merck.